期刊文献+

代谢异常人群糖耐量与胰岛功能及胰岛素作用的关系 被引量:1

Relationship between glucose tolerance and the functions of pancreatic β-cell and insulin in people with abnormal metabolism
原文传递
导出
摘要 目的探讨不同糖耐量状态的代谢高危人群胰岛功能及胰岛素作用的变化。方法选择体检人群中筛查出无糖尿病史的代谢异常者334例,行口服葡萄糖耐量试验(OGTT)及胰岛素、C肽释放试验,计算胰岛素敏感指数(IAI)、胰岛素抵抗指数(IR)、胰岛素分泌指数(HBCI)和空腹β细胞功能指数(FBCI)。根据OGTT结果分为三组:糖耐量正常(NGT组,218例),糖调节受损(IGR组,93例)和糖尿病(DM组,23例),比较三组人群胰岛功能的变化。结果与NGT组比较,IGR组及DM组腰围、体重指数(BMI)、低密度脂蛋白(LDL)、胰岛素、IR升高,IAI、HBCI降低(P<0.05)。结论随糖耐量状态恶化代谢异常人群高胰岛素血症加重,胰岛素敏感性逐步降低,胰岛细胞功能呈衰退趋势。 Objective To study the relationship between glucose tolerance and the functions of pancreatic β-cell and insulin in people with abnormal metabolism. Methods A total of 334 non-diabetic cases with abnormal metabolism was screened from the subjects underwent medical examination. The oral glucose tolerance test(OGTT) and insulin,C-peptide release test were carried out,and insulin sensitivity index(IAI),insulin resistance index(IR),insulin secretion index(HBCI or HOMA-β) and fasting β cell function index(FBCI) were calculated.According to OGTT results,the subjects were categorized into three groups of NGT (218 cases with normal glucose tolerance),IGR(93 cases with impaired glucose regulation) and DM(23 cases with diabetes mellitus).Those indices were compared among three groups. Results Compared with group NGT,the waist circumference,BMI,LDL,insulin and IR in groups of IGR and DM were higher,but IAI and HBCI were lower significantly(P0.05). Conclusion As the glucose tolerance state is decreasing in people with metabolic abnormality,a tendecy of decreased insulin sensitivity and increased damage of pancriatic β-cell function.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第6期673-675,共3页 Jiangsu Medical Journal
基金 江苏省卫生厅指导性科研课题(Z200901)
关键词 代谢异常人群 胰岛功能 糖尿病 Metabolic abnormal people Insulin function Diabetes
  • 相关文献

参考文献6

二级参考文献29

  • 1Ninomiya JK, L' Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the third national health and nutrition examination survey[J]. Circulation, 2004,109:42-46.
  • 2Cohn G, Valdes G, Capuzzi DM. Pathophysiology and treatment of the dyshpidemia of insulin resistance[J]. Curr Cardiol Rep,2001,3:416-423.
  • 3Oh JY, Barrett-Connor E. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in conmatmity-dwelling older adults: the Rancho Bemardo Study [ J ]. Metabolism, 2002,51:356-359.
  • 4Vitalian PP, Scanlan JM, Zhang J, et al. A path model of chronic stress, the metabolic syndrome, and coronary heart disease[J]. Psychosom Med, 2002,64: 418-435.
  • 5Bjomtorp P. Do stress reactions cause abdominal obesity and comorbidities[J]. Obes Rev,2001,2:73-86.
  • 6Whorwood CB, Donovan S J, Flanagan D, et al. Increased glucocorticoid receptor expression in skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome[J]. Diabetes, 2002, 51 :1066-1075.
  • 7Isomaa B, Aimgren P, Tuomi T, et al. Cardiovasetdax morbidity and mortality associated with the metabolic syndrome[J]. Diabetes Care,2001,24: 683-689.
  • 8Boden WE. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Demity Lipoprotein Intervention Trial[Jl. Am J Cardiol. 2000,86(12A) :19L-22L.
  • 9Groop L, Orho-Melander M. The dysmetabolic syndrome. J Intern Med, 2001, 250:105-120.
  • 10Malloy MJ, Kane JP. A risk factor for atherosclerosis: triglyceriderich lipoproteins[J]. Adv Intern Med. 2001,47:111-136.

共引文献607

同被引文献12

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部